1.
Molica S, Sportoletti P, Di Renzo N, Musto P, Pane F, Di Raimondo F. Treatment of relapsed/refractory CLL with Venetoclax-Rituximab during the COVID-19 pandemic: A daily-life experience in southern Italy. Mediterr J Hematol Infect Dis [Internet]. 2021 Jun. 28 [cited 2021 Nov. 27];13(1):e2021042. Available from: https://mjhid.org/index.php/mjhid/article/view/4613